A contract research organization that runs clinical trials and outsourced drug-development services for pharmaceutical, biotechnology, and medical device companies around the world. Founded in Dublin in 1990 by two doctors who started with a team of five, the name ICON is not an acronym — it was simply chosen to reflect the company's focus on clinical research. It even built a "Country-in-a-Box" service to help clients launch trials in unfamiliar markets.
ICON plc subsidiary issues $2.15B senior notes in private placement
On August 13, 2026, ICON Investments Six Designated Activity Company issued $2.15 billion of senior unsecured notes in three tranches: $500M at 5.064% due 2029, $1.0B at 5.421% due 2031, and $650M at 5.995% due 2036.
Show detailsHide details
The notes are guaranteed on a senior unsecured basis by ICON plc and were sold in a private placement to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S.
Net proceeds were used to repay all outstanding term loans under ICON's senior secured term loan facility, redeem in full the Issuer's 5.809% Senior Secured Notes due 2027, and repay all outstanding borrowings under ICON Global Treasury's bridge facility.
Upon repayment, collateral securing ICON's revolving credit facility and existing notes, along with subsidiary guarantees, were automatically released.
The Issuer agreed to use commercially reasonable efforts to file a registration statement for an exchange offer for the notes, to be consummated no later than November 11, 2027.
ICON prices $2.15B senior notes offering to refinance debt
ICON's subsidiary ICON Investments Six Designated Activity Company priced $2.15 billion of senior unsecured notes in three tranches: $500M at 5.064% due 2029, $1.0B at 5.421% due 2031, and $650M at 5.995% due 2036.
Show detailsHide details
The notes are guaranteed on a senior unsecured basis by ICON plc and are offered privately under Rule 144A and Regulation S.
Net proceeds will repay the bridge secured credit facility, existing term loans, and redeem in full the 5.809% Senior Secured Notes due 2027.
Upon repayment, collateral and subsidiary guarantees securing ICON's revolving credit facility and existing notes will be automatically released.
The offering is expected to close on August 13, 2026, subject to customary closing conditions.
ICON plc shareholders pass all resolutions at 2026 Annual General Meeting
Shareholders re-elected eight directors and elected three new directors, including Barry Balfe, Kevin Egan, and Jeff Elliott.
Show detailsHide details
All resolutions at ICON plc's AGM held on July 31, 2026 were duly passed by shareholders.
Resolutions included approval of accounts, auditor remuneration, share allotment authority, and disapplication of pre-emption rights.
Special resolutions to disapply pre-emption rights for funding capital investment or acquisitions passed with 64,417,316 votes for and 3,962,733 against.
The company also received authorization to make overseas market purchases of shares and to reissue treasury shares within a specified price range.
ICON plc announces AGM for 31 July 2026 with director elections and share issuance authorities
ICON plc will hold its Annual General Meeting on 31 July 2026 at 11:00am Dublin time at its global headquarters in Leopardstown, Dublin.
Show detailsHide details
All ten current directors, including new appointees Kevin Egan and Jeff Elliott, will stand for election or re-election.
Shareholders will vote on ordinary resolutions to approve 2025 accounts, fix auditor remuneration, and authorize share issuance up to 20% of share capital.
Special resolutions seek authority to issue up to 10% of share capital without pre-emptive rights, plus an additional 10% for acquisitions or capital investments.
The company also seeks authority to buy back up to 10% of shares and to reissue treasury shares within a price range of 95% to 120% of the average closing price.
Directors recommend voting in favor of all resolutions; they hold 326,412 ordinary shares (approximately 0.42% of issued capital) as of 18 June 2026.